[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334626-105":59,"doc-detail-334626-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","nano-drug-delivery-systems-targeting-cafs-a-promising-treatment-for-pancreatic-cancer","Nano-Drug Delivery Systems Targeting CAFs - A Promising Treatment for Pancreatic Cancer","","Pancreatic cancer remains one of the most lethal malignancies, commonly diagnosed at late stages and showing poor response to conventional modalities, with survival largely stagnant since the 1960s. Cancer-associated fibroblasts (CAFs) are key drivers within the tumor microenvironment, supporting matrix maintenance and complex signaling to cancer and immune cells. This review evaluates CAF origins, heterogeneity, targets, and recent nano-drug delivery advances, proposing combined nano-targeting with radiotherapy and immunotherapy while outlining current challenges.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/nano-drug-delivery-systems-targeting-cafs-a-promising-treatment-for-pancreatic-cancer/334626/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/nano-drug-delivery-systems-targeting-cafs-a-promising-treatment-for-pancreatic-cancer/334626.png","ImageObject",300,407,{"name":92,"@type":93},"Lucas Martin","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is pancreatic cancer difficult to treat with conventional therapies?","Question",{"text":112,"@type":113},"Pancreatic cancer is often resistant to surgery, chemotherapy, radiotherapy, and immunotherapy, and many patients are diagnosed at an advanced stage. Its rich tumor microenvironment creates pro-tumor signals and forms a physical barrier that limits drug penetration.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What roles do cancer-associated fibroblasts (CAFs) play in pancreatic cancer?",{"text":117,"@type":113},"CAFs are crucial components of the tumor microenvironment and contribute to the tumor’s physical barrier. Different CAF subtypes secrete regulatory factors that support pancreatic cancer proliferation, invasion, and metastasis.",{"name":119,"@type":110,"acceptedAnswer":120},"How do nano-drug delivery systems contribute to CAF-targeted treatment?",{"text":121,"@type":113},"Nano-drug delivery systems enable accurate targeting and stimulus-responsive, spatiotemporal release with minimal toxicity to normal tissues. They may also disrupt signaling and energy metabolism pathways after cellular entry, supporting strategies to modulate CAF functions.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334626,1791306735,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","International Journal of Nanomedicine Dovepress  \nopen access to scientific and medical research  \n Open Access Full Text Article REVIEW  \nNano-Drug Delivery Systems Targeting CAFs: A Promising Treatment for Pancreatic Cancer  \nMingjie Wang 1 , *, Wenxiang Xue2 , *, Hanghang Yuan2 , Zhicheng Wang2 , Lei Yu 1  \n1Department of Radiotherapy, Second Hospital of Jilin University, Changchun, Jilin, People’s Republic of China; 2NHC Key Laboratory of Radiobiology, School of Public Health, Jilin University, Changchun, Jilin, People’s Republic of China  \n*These authors contributed equally to this work  \nCorrespondence: Zhicheng Wang; Lei Yu, Tel +86-431-85619443, Email [zhicheng@jlu.edu.cn](zhicheng@jlu.edu.cn); [yul0826@163.com](yul0826@163.com)  \n\n| Abstract: Currently, pancreatic cancer (PC) is one of the most lethal malignant tumors. PC is typically diagnosed at a late stage, exhibits a poor response to conventional treatment, and has a bleak prognosis. Unfortunately, PC’s survival rate has not significantly improved since the 1960s. Cancer-associated fibroblasts (CAFs) are a key component of the pancreatic tumor microenvironment (TME) . They play a vital role in maintaining the extracellular matrix and facilitating the intricate communication between cancer cells and infiltrated immune cells. Exploring therapeutic approaches targeting CAFs may reverse the current landscape of PC therapy. In recent years, nano-drug delivery systems have evolved rapidly and have been able to accurately target and precisely release drugs with little or no toxicity to the whole body. In this review, we will comprehensively discuss the origin, heterogeneity, potential targets, and recent advances in the nano-drug delivery system of CAFs in PC. We will also propose a novel integrated treatment regimen that utilizes a nano-drug delivery system to target CAFs in PC, combined with radiotherapy and immunotherapy. Additionally, we will address the challenges that this regimen currently faces.\u003Cbr>Keywords: nanoparticle, nano-drug delivery system, cancer-associated fibroblasts, pancreatic cancer, tumor microenvironment |\n| --- |\n| Introduction\u003Cbr>Pancreatic cancer (PC) is a highly aggressive disease that has been causing a gradual increase in morbidity and mortality. In recent decades, only about 4% of patients have been able to survive 5 years after diagnosis. The survival rate of PC has stagnated due to its resistance to current conventional therapies, including surgery, chemotherapy, radiotherapy, and immunotherapy. Additionally, the fact that most patients are detected at an advanced stage contributes to the challenge.1 The resistance of PC to current therapeutic modalities is primarily attributed to the structural characteristics of PC itself, as it is surrounded by a rich tumor microenvironment (TME) . The rich TME not only produces various pro-tumor growth and metastatic active factors, but also serves as a physical barrier preventing drug penetration from reaching the tumor.2 Cancer-associated fibroblasts (CAFs) play a crucial role in the composition of the TME, which is a major component in the composition and regulation of the tumor’s physical barrier. CAFs can be differentiated from normal fibroblasts and PC astrocytes and they can be classified into numerous subtypes.3 Different subtypes of CAFs secrete a variety of regulatory factors that play crucial roles in PC proliferation, invasion, and metastasis. However, recent studies have shown that excessive depletion of CAFs accelerates tumor progression.4 CAFs, with their pro-tumorigenic and antitumorigenic functional heterogeneity, are promising targets for the treatment of PC. Currently, there are no effective therapeutic modality available to improve the prognosis of PC. Novel regimens targeting the CAFs that comprise the TME may revolutionize the current landscape of PC treatment. The ability to remodel the TME to reverse the physical barrier that protects tumor cells and creates a rapid pathway fo","cbCaidEa22Ec2EPG","https://ap.wps.com/l/cbCaidEa22Ec2EPG","pdf",4746275,27,"English","# Introduction\n## Pancreatic cancer burden and treatment resistance\n## Tumor microenvironment barrier and CAF roles\n## Rationale for targeting CAFs with nano-drug delivery systems","[{\"question\":\"Why is pancreatic cancer difficult to treat with conventional therapies?\",\"answer\":\"Pancreatic cancer is often resistant to surgery, chemotherapy, radiotherapy, and immunotherapy, and many patients are diagnosed at an advanced stage. Its rich tumor microenvironment creates pro-tumor signals and forms a physical barrier that limits drug penetration.\"},{\"question\":\"What roles do cancer-associated fibroblasts (CAFs) play in pancreatic cancer?\",\"answer\":\"CAFs are crucial components of the tumor microenvironment and contribute to the tumor’s physical barrier. Different CAF subtypes secrete regulatory factors that support pancreatic cancer proliferation, invasion, and metastasis.\"},{\"question\":\"How do nano-drug delivery systems contribute to CAF-targeted treatment?\",\"answer\":\"Nano-drug delivery systems enable accurate targeting and stimulus-responsive, spatiotemporal release with minimal toxicity to normal tissues. They may also disrupt signaling and energy metabolism pathways after cellular entry, supporting strategies to modulate CAF functions.\"}]","Nano-Drug Delivery Systems Targeting CAFs - A Promising Treatment for Pancreatic Cancer | PDF",1790007564,68]